news

Subscribe to our newsletter

Send us a link

Science and the Shutdown: 5 Things to Watch As US Impasse Drags on

Science and the Shutdown: 5 Things to Watch As US Impasse Drags on

A second wave of closures looms as the government funding fight barrels towards a record-breaking fourth week.

Scientists Despair As US Government Shutdown Drags on

Scientists Despair As US Government Shutdown Drags on

Space missions can continue to collect data, but thousands of federal researchers are forced to stay home without pay.

AI-enhanced Peer Review: Frontiers Launches Next Generation of Efficient, High-quality Peer Review

AI-enhanced Peer Review: Frontiers Launches Next Generation of Efficient, High-quality Peer Review

The integration of AIRA - Artificial Intelligence Review Assistant - into Frontiers' digital peer-review platform enables faster, more efficient quality control and manuscript handling.

Donald Trump Finally Has a White House Science Adviser

Donald Trump Finally Has a White House Science Adviser

Senate confirms meteorologist Kelvin Droegemeier to lead the White House Office of Science and Technology Policy.

Federal Shutdown Includes Agencies That Are Key Supporters of University Research

Federal Shutdown Includes Agencies That Are Key Supporters of University Research

Grant checks from NSF and other funders won't go out. Meetings on grant applications won't take place. Impact will grow with length of standoff. Trump threat on border with Mexico alarms some Texas campuses.

UC and Elsevier - Office of Scholarly Communication

UC and Elsevier - Office of Scholarly Communication

The University of California is re-negotiating its systemwide licenses with some of the world's largest scholarly journal publishers, including Elsevier, to provide additional open access options for UC authors. In these negotiations, the UC is seeking a single, integrated contract with each publisher that covers both the university's subscriptions and open access publishing of UC research in their journals - what are often known as "publish and read" agreements.

Max Planck Society Discontinues Agreement with Elsevier

Max Planck Society Discontinues Agreement with Elsevier

The Max Planck Society is going to discontinue their Elsevier subscription. By doing so the Society joins nearly 200 universities and research institutions in Germany who have already cancelled their agreements with Elsevier.

Elsevier Willing to Compensate Editors to Prevent Them from 'Flipping'

Elsevier Willing to Compensate Editors to Prevent Them from 'Flipping'

As some editors are moving to 'flip' their journal the publishing giant offers considerable compensations to change their minds.

Elsevier Acquires Science-Metrix Inc., Provider of Research Analytics Services and Data

Elsevier Acquires Science-Metrix Inc., Provider of Research Analytics Services and Data

Elsevier,  the information analytics business specializing in science and health, has acquired Science-Metrix Inc., a research evaluation firm that provides science research evaluation and analytics to assess science and technology activities

Discovered: The Most-Distant Solar System Object Ever Observed

Discovered: The Most-Distant Solar System Object Ever Observed

A team of astronomers has discovered the most-distant body ever observed in our Solar System. It is the first known Solar System object that has been detected at a distance that is more than 100 times farther than Earth is from the Sun. It was announced Monday by the International Astronomical Union's Minor Planet Center. Carnegie's Scott S. Sheppard, the University of Hawaii's David Tholen, and Northern Arizona University's Chad Trujillo made the discovery.

China Introduces 'Social' Punishments for Scientific Misconduct

China Introduces 'Social' Punishments for Scientific Misconduct

Offending researchers could face restrictions on jobs, loans and business opportunities under a system tied to the controversial social credit policy.

Ideation and Implementation of an Open Science Drug Discovery Business Model

Ideation and Implementation of an Open Science Drug Discovery Business Model

M4K Pharma was incorporated to launch an open science drug discovery program that relies on regulatory exclusivity as its primary intellectual property and commercial asset, in lieu of patents. In many cases and in key markets, using regulatory exclusivity can provide equivalent commercial protection to patents, while also being compatible with open science. The model is proving attractive to government, foundation and individual funders, who collectively have different expectations for returns on investment compared with biotech, pharmaceutical companies, or venture capital investors.In the absence of these investor-driven requirements for returns, it should be possible to commercialize therapeutics at affordable prices. M4K is piloting this open science business model in a rare paediatric brain tumour, but there is no reason it should not be more widely applicable.

Elsevier in 2018: Decrease in Number of Fully OA Journals

Elsevier in 2018: Decrease in Number of Fully OA Journals

In 2018, there has been a drop in the number of fully OA journals published by Elsevier, from 416 to 328 journals. The majority of Elsevier’s fully OA journals are still non-charging.

Parachute Use to Prevent Death and Major Trauma when Jumping from Aircraft: Randomized Controlled Trial

Parachute Use to Prevent Death and Major Trauma when Jumping from Aircraft: Randomized Controlled Trial

Systemic Reforms and Further Consultation Needed to Make Plan S a Success

Systemic Reforms and Further Consultation Needed to Make Plan S a Success

ALLEA welcomes the ambition of the coalition of European research funders to move the scientific publishing system towards open access; however, broader consultation with all parties is required during the implementation phase.